We found that the administration of fresh royal jelly could alleviate the condition of hepatocellular carcinoma patients in a certain extent. The human hepatocellular carcinoma cell line SMMC-7721 was cultured in vitro. MTT colorimetric method was used to treat fresh cells and serum containing human serum. The effect of SMMC-7721 proliferation was observed. Results: The aqueous solution of fresh royal jelly had a certain effect on the proliferation of hepatoma cell line SMMC-7721 in a dose-dependent manner. The serum containing fresh royal jelly could inhibit the proliferation of human hepatoma cell line SMMC-7721, and its inhibitory effect showed dose-dependent. Conclusion: The serum containing fresh royal jelly has a significant inhibitory effect on the proliferation of human hepatoma cell line SMMC-7721 and its anti-cancer effect may be derived from its metabolites or stimulating the formation of immune-reactive substances in the body, in which in the clinical treatment of liver cancer and research have a certain value.
Introduction
Hepatocellular carcinoma is one of the most common malignancies in the world. The data show that it is in the 6th place in the global malignancy. It is ranked 5th in China and the second in the world and the death of malignant tumor in China. And the mortality rate accounts for about half of the world. Although China through the injection of hepatitis B vaccine shown a significant reduction in the rate of hepatitis B virus infection and antiviral treatment slowed the progress of hepatitis B, hepatitis C and cirrhosis patients to a certain extent, so that the occurrence of liver cancer and mortality decreased significantly, minimally invasive. Timely surgery to extend the survival time of some patients with liver cancer, molecular biology research progress was given the new treatment which may be, but still a drop in the bucket, it is still a medical problem, the patient's life killer. Therefore, the use of integrated medical control means of its full intervention is to improve the survival rate of patients to extend the survival time in the most effective way.
Royal jelly is mainly the by products from the worker bee pharyngeal gland, palatal gland secretion of a slurry material which contains a variety of active substances and rich in nutrients, such as protein, vitamin A, B2, C, E, trace elements germanium, selenium, more importantly is that it also contains a special unsaturated fatty acid (sunflower acid) and flavonoids, which can regulate of cells and humoral immunity to achieve significant anti-cancer effect, thus it was classified as pure natural health products [1] . In recent years, the medicinal value of royal jelly at home and abroad has been widely concerned by the clinical medicine community and gradually applied to cancer patients in the immunotherapy process. We investigated the effects of royal jelly and in vitro on the proliferation of human hepatocellular carcinoma cell line SMMC-7721 in order to explore its mechanism.
The results are reported as follows.
Materials and method

Experimental material
The human hepatocellular carcinoma cell line provide. In addition, from Nanjing Junke Biological Engineering Co., Ltd. purchased 180~200g male SD rats.
Method
Preparation of fresh royal jelly aqueous solution
In serum-free RPMI1640 added fresh royal jelly, the mixture prepared into a 0.2mg/ml concentration of the suspension, the use of chemical analysis filter paper filter and then under the action of 0.22um microporous membrane. The bacteria were filtered and the filtrate was taken and diluted to 0.002, 0.02 and 0.2 mg/ml for a variety of concentrations.
Cell proliferation detection method
By using MTT colorimetric method for cell proliferation detection. In the 96-well plate, 2 × 104 cells/ml on single cell suspension, 100ul/well. After confirming the cell growth status, the supernatant was discarded and the appropriate serum-free culture medium was added to keep the serum in a hungry state and the supernatant was discarded. Then, the supernatant was discarded and different concentrations of fresh royal jelly solution containing serum was added, so that the serum concentration remained at 10%, fresh royal jelly solution at different concentrations of 0.001, 0.01 and 0.1mg/ml. 10% FBS medium was used as the control group, and cultured for about 48 hours. 0.5% MTT was added. After incubation for 4 hours, the supernatant was discarded and DMSO150uj was added. The microcrystals were used for the oscillation, in which 10min is appropriate.
At 490nm UV visible microplate detection to determine its absorbance value.
Preparation of serum
20 male SD rats were randomly divided into control group and observation group, the control group: given normal saline gavage, observation group: given 0.5g/kg royal jelly, 10ml /kg, 2 Times/d, the two groups were fed continuously for 10 days for 12 h before the last administration of fasting and after 1 h of administration, given the carotid artery intubation and the implementation of sterile blood collection and collection of blood preservation to 8h is appropriate and then given centrifugal treatment, the centrifugal rate remained at 3000r/min, in which to 10min is appropriate for the separation of serum. And then use 0.22um microporous membrane filter on the bacteria, after packaging in -20 ℃ environment to be preserved.
Before use at 56 ℃ under the conditions to distinguished fire and in serum-free RPMI1640 medium and diluted into the experimental study of the required concentration, kept for the reservation purposes.
Detection of Cell Proliferation at Different
Concentrations
The serum concentration was 10%, 20% and 40% respectively. The concentration of the serum was set in different dose groups. The FBS control group and the serum control group included 6 wells, 100ul / % Serum concentration of 5% and 10% of the two doses of serum; 20% serum concentration of serum containing 5%, 10%, 20% of the three different doses, 40% of the serum concentrations were 5% , 10%, 20% and 40% of the serum dose of 4 doses. The detection method is the same as 1.2.2. The inhibition rate of cell proliferation was calculated by the formula (1-MS group A mean / BS group A mean) × 100% 
Statistical analysis
Results
Effect of aqueous solution of royal jelly on the proliferation of hepatoma cell line SMMC -721
The results showed that the absorbance at different doses of royal jelly group was significantly higher than that of control group (P <0.05), which was statistically significant and showed significant dose-dependent, as shown in Table 1 .
Effect of royal jelly serum on proliferation of hepatocellular carcinoma cell line
The results showed that serum containing SMMC-7721 could inhibit the proliferation of human hepatoma cell line SMMC-7721, which was significantly higher than that of control group (P <0.05) and the difference was 
Discussion
Royal jelly is the food for life of the queen bee, its life is generally 3-4 years, the elderly up to 8 years, while [2] , repair the role of DNA damage. Foreign scholars in the study found that royal jelly in a large number of trace elements selenium, vitamin A and royal jelly acid and other substances, which can inhibit the growth of cancer cells [3] [4] [5] [6] , the material part of the water-soluble, partially non-water soluble, the usage of culture in this study to dissolve royal jelly, in vitro its role in the cell is mainly water-soluble components, non-water-soluble components in the presence of tumor suppressor substances which are often removed to participate in the reaction system of the liver cancer cells The inhibitory effect of growth is largely masked [7] [8] and the role of serum containing drugs in the body, the mechanism is more complex, which may improve the immune function to a certain extent and activate the body's immune active substances and play an anti-cancer effect. Royal jelly in vitro culture of cancer cells directly, failed to fully participate in the process of the body, its anti-cancer effect failed to play, but to promote the proliferation of cancer cells [9] . The results showed that the absorbance values of different doses of royal jelly aqueous solution were significantly higher than those of the control group (P <0.05), which was statistically significant and showed significant dose-dependent. The serum of the rat serum was significantly higher than that of the control group (P <0.05), and the serum level of SMMC-7721 was significantly higher than that of the control group [10] .
Cell growth promotion was more significant, the difference was statistically significant (P <0.05). In conclusion, the aqueous solution of royal jelly has a certain effect on the proliferation of hepatocarcinoma cell line SMMC-7721 in vitro, and the drug-containing serum has a significant inhibitory effect on the proliferation of hepatoma cell line SMMC-7721, which is consistent with the related domestic and foreign studies. In other words, promote the therapeutic value of royal jelly on liver cancer.
